ClinicalTrials.Veeva
Menu

Find clinical trials for Melanoma in Miami, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Cancer
Squamous Cell Carcinoma of Head and Neck
Neoplasm Metastasis
Renal Cell Carcinoma
Colorectal Cancer
Carcinoma

Melanoma trials near Miami, FL, USA:

Status recently updated

(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

Neoadjuvant/adjuvant IDE196 (darovasertib) in patients with primary uveal melanoma...

Enrolling
Active, not recruiting
Uveal Melanoma
Drug: Darovasertib

Phase 2

Ideaya Biosciences

Miami, Florida, United States and 17 other locations

and overall survival (OS) for patients with NRAS-mutant (NRASm) melanoma who are randomized to receive the combination of naporafenib + tram...

Active, not recruiting
Advanced or Metastatic NRAS-mutant Melanoma
Drug: Trametinib
Drug: Naporafenib

Phase 3

Erasca

Miami, Florida, United States and 58 other locations

The study is focused on patients with a type of skin cancer known as melanoma. The aim of the study is to see how safe and effective the com...

Enrolling
Melanoma
Drug: fianlimab
Drug: cemiplimab

Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Tamarac, Florida, United States and 107 other locations

efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminate lesions (IL) or small choroidal melanoma...

Enrolling
Ocular Melanoma
Choroidal Melanoma
Device: Suprachoroidal Microinjector
Drug: Bel-sar

Phase 3

Aura Biosciences
Aura Biosciences

Miami, Florida, United States of America and 72 other locations

sub-type 1 receptor (MC1R) is being evaluated as a monotherapy and in combination with nivolumab in subjects with unresectable and metastatic melanoma...

Enrolling
Melanoma Stage IV
Melanoma Stage III
Drug: Nivolumab
Drug: [212Pb]VMT01

Phase 1, Phase 2

Perspective Therapeutics

Miami, Florida, United States and 14 other locations

To evaluate the overall survival of HLA-A\*0201 positive adult patients with previously untreated advanced UM receiving IMCgp100 compared to Investig...

Active, not recruiting
Uveal Melanoma
Biological: IMCgp100
Biological: Pembrolizumab

Phase 2

Immunocore
Immunocore

Miami, Florida, United States and 56 other locations

antigen (HLA)-A\*02:01 negative participants with metastatic uveal melanoma (MUM) who will be randomized to receive either IDE196 + crizotin...

Active, not recruiting
Metastatic Uveal Melanoma
Drug: IDE196
Drug: Nivolumab

Phase 2, Phase 3

Ideaya Biosciences

Miami, Florida, United States and 67 other locations

attracting MDSCs. This first study will enroll participants with melanoma, as melanoma cancer has been shown to be able to attract ...

Active, not recruiting
Melanoma Stage IV
Melanoma Stage III
Drug: SX-682
Biological: Pembrolizumab

Phase 1

Syntrix Biosystems

Miami, Florida, United States and 5 other locations

The purpose of this study is to see if giving participants quisinostat will prevent participants' uveal melanoma tumor from spreading. The r...

Enrolling
Uveal Melanoma
Drug: Quisinostat

Phase 2

University of Miami
University of Miami

Miami, Florida, United States

the effects (good and bad) that Tebentafusp in combination with Yttrium-90 (Y-90) radioembolization has on patients with metastatic uveal melanoma...

Enrolling
Metastatic Uveal Melanoma
Metastatic Uveal Melanoma in the Liver
Radiation: TheraSphere™ Yttrium-90 Trans-Arterial Radioembolization
Drug: Tebentafusp

Phase 2

University of Miami
University of Miami

Miami, Florida, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems